Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

University Hospital, Basel, Switzerland60 enrolled

Overview

the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Healthy Polyuria-polydipsia Syndrome

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age over 18 years 2. No medication except hormonal contraception Exclusion Criteria: 1. Evidence of any acute illness 2. Subjects refusing or unable to give written informed consent 3. Pregnancy 4. Any evidence of disordered drinking habits and diuresis

Locations (1)

University Hospital Basel

Basel, Canton of Basel-City, Switzerland

Outcomes

Primary Outcomes

Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.

Time frame: up to 120 minutes after the Arginine infusion.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.